These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 16151394)

  • 1. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A piece of history.
    Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894179
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech pharmaceuticals and biotherapy: an overview.
    Steinberg FM; Raso J
    J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 5. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 6. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

  • 7. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotech unruffled by setbacks.
    Glaser V
    Nat Biotechnol; 1997 Jul; 15(7):610-1. PubMed ID: 9219254
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond the lab in biotech. With so many drugs in trial, new jobs are opening up.
    Carmichael M
    Newsweek; 2002 Sep; 140(13):53. PubMed ID: 12375414
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibodies in the clinic.
    Reichert JM
    Nat Biotechnol; 2001 Sep; 19(9):819-22. PubMed ID: 11533635
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA requires further trials for antiendotoxin monoclonal antibody products.
    Am J Hosp Pharm; 1992 Aug; 49(8):1848, 1850. PubMed ID: 1442827
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 15. Flexibility--the guiding principle for antibody manufacturing.
    Carson KL
    Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How FDA approves biotechnology drugs.
    Manuel SM; Piascik P
    Am Pharm; 1995 May; NS35(5):14-5. PubMed ID: 7611131
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward biosimilar monoclonal antibodies.
    Schneider CK; Kalinke U
    Nat Biotechnol; 2008 Sep; 26(9):985-90. PubMed ID: 18779806
    [No Abstract]   [Full Text] [Related]  

  • 18. Translation of cancer immunotherapies.
    Skipper J; Hoffman EW; O'Donnell-Tormey J; Old LJ
    Nat Med; 2004 Nov; 10(11):1154-5; author reply 1155. PubMed ID: 15516901
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the drought over for pharming?
    Kaiser J
    Science; 2008 Apr; 320(5875):473-5. PubMed ID: 18436771
    [No Abstract]   [Full Text] [Related]  

  • 20. Trials and error.
    Jacobs T
    Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.